Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Morden JP"'
Treatment crossover occurs when patients randomised to the control group of a clinical trial are permitted to switch onto the experimental treatment at some point during follow-up. It is common in oncology trials for a number of reasons, both practic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca8f8c716bf50f5a2e48e41ee29ee8d
Autor:
Cameron, D, Morden, JP, Canney, P, Velikova, G, Coleman, R, Bartlett, J, Agrawal, R, Banerji, J, Bertelli, G, Bloomfield, D, Brunt, AM, Earl, H, Ellis, P, Gaunt, C, Gillman, A, Hearfield, N, Laing, R, Murray, N, Couper, N, Stein, RC, Verrill, M, Wardley, A, Barrett-Lee, P, Bliss, JM
Publikováno v:
Cameron, D, Morden, J P, Canney, P, Velikova, G, Coleman, R, Bartlett, J, Agrawal, R, Banerji, J, Bertelli, G, Bloomfield, D, Brunt, A M, Earl, H, Ellis, P, Gaunt, C, Gillman, A, Hearfield, N, Laing, R, Murray, N, Couper, N, Stein, R C, Verrill, M, Wardley, A & Barrett-Lee, P & Bliss, J M 2017, ' Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial ', The Lancet Oncology, vol. 18, no. 7, pp. 929-945 . https://doi.org/10.1016/S1470-2045(17)30404-7
The Lancet. Oncology
The Lancet. Oncology
Background: Adjuvant chemotherapy for early breast cancer has improved outcomes but causes toxicity. The UK TACT2 trial used a 2×2 factorial design to test two hypotheses: whether use of accelerated epirubicin would improve time to tumour recurrence
Autor:
Mieog, Js, Morden, Jp, Bliss, Jm, Coombes, Rc, van de Velde CJ, IES Steering Committee: Delozier, T, Veronesi, A, Vrdoljak, E, Monnier, A, Coombes, C, Nagykalnai, T, Roumen, Rm, Utracka Hutka, B, Pluzanska, A, Porpiglia, M, Genta, F, Benedetto, Chiara, Sozzani, P, Steiner, M, Rubinov, R, Leviov, M, Semiglazov, V, Fox, J, Mayordomo, Ji, Cervek, J, Sleeboom, Hp, Jassem, J, Hinton, Cp, Paulsen, Th, Guleng, Rj, Fein, L, Gutulescu, N, Florián, J, Rosso, R, Rutgers, Ej, Krzakowski, M, Pienkowski, T, Krajina, Z, Siffnerova, H, Pawlicki, M, Drosik, K, Wagnerowa, M, Brunt, M, Vukelja, S, Mitrowic, L, Cataliotti, L, Karnicka Mlodkowska, H, Bonnefoi, H, Tilch, G, Chollet, P, Patel, A, Kamby, C, Giustini, L, Acito, L, Mouridsen, H, Roche, H, De Lafontan, B, Tomczak, P, Petruzelka, L, Lortholary, A, Pacquola, Mg, Skene, A, Rici, S, Michelotti, A, Ghilezan, N, Stewart, A, Beauduin, M, Andersen, J, Vassilaros, S, Celio, L, Bajetta, E, Bastús, R, Marsland, T, Paridaens, R, Tzekova, V, Lichtenegger, W, Piersma, H, Jones, S, Holmberg, S, Verhoeven, D, Hill, A, Porcile, G, Bruno, Mf, Chernozemski, I, Coleman, R, Jadeja, J, Cohn, A, Merlano, M, Perroni, D, Di Costanzo, F, Van Bochove, A, Gerrits, Ma, Malec, V, Balil, A, Mendiola, C, Dodwell, D, Knox, R, Horgan, K, Joannides, T, Leonard, Rc, Cawthorn, Sj, Ghosh, C, Cantrell, J, Campos, D, Orti, R, Diedrich, K, Aas, H, Barnadas, A, Vila, Mm, Makris, A, Anderson, T, Chittor, S, Michel, J, Philip, P, Redmond, P, Mastboom, Wj, Nordenskjöld, B, Simmonds, P, Grieve, Rj, Tomova, A, Piot, G, Borea, G, Ucci, G, Einarsson, E, Nicholson, S, Gardiol, Ea, Kerger, J, Schlosser, J, Namer, M, Pinotti, G, Rutten, Ht, Iversen, T, Nejim, A, Dudov, A, Grundtvig, P, Lang, I, Massidda, B, Van De Velde CH, Gervasio, Mh, Tengrup, I, Tennvall, L, Goodman, S, Modgill, Vk, Vorobiof, Da, Mickiewicz, E, Chirgwin, J, Focan, C, Albin, N, Contu, Aa, Svensson, Jh, Borghede, G, Källström, Ac, Forbes, Jf, Hurtz, Hj, Tubiana Hulin, M, Viens, P, Scanni, A, Arnoldi, E, Nastasi, G, Bottini, A, Alquati, P, Muscat, V, Brincat, S, Holmen, K, Amaral, N, Moreno, I, Trask, C, Robinson, A, Mcintyre, K, Otsuka, A, Hohaus, B, Hoefig, G, Georgoulias, V, Salvagni, S, Bidin, L, Artioli, F, Engan, T, Benedikstsson, Kp, Campbell, I, Harvey, V, Zimbler, H, Mrsic Krmpotic, Z, Canon, Jl, Tchilingirov, Pv, Buser, K, Bolanca, A, Reztke, U, Rhein, U, Jouve, M, Mullins, G, Vesentini, L, Gallo, L, Merlini, L, Decensi, A, Carreca, I, Van Tienhoven, G, Börjesson, B, Hansen, J, Koza, I, Arcusa, A, Inoriza, A, Pelegri, A, Eremin, O, Modiano, Mr, Anthony, S, Donat, D, Richardet, E, Kochli, O, Zeißig, P, Gauch, G, Aabo, K, Fumoleau, P, Erdkamp, Fl, Lovén, L, Jönsson, Pe, Perren, T, Stuart, N, Galindo, E, Marek, Bj, Salmon, Jp, Dohollou, N, Thompson, R, Folco, U, Rosa, A, Tonato, M, Heijmans, Gj, Koralewski, P, Bång, H, Lescure, Ar, Carrato, A, Martin, M, Neave, F, Howell, T, Savin, M, Loesch, D, Hannois, A, Mohr, A, Laube, T, Omar, S, Bonneterre, J, Servent, V, Danese, S, Sertoli, Mr, Butzelaar, Rm, Steller, Ep, Gomez, H, Skoog, P, Alvarez, I, Aguilar, Ea, Giner, Jl, Yosef, Hm, Barrett Lee, P, Buzdar, Au, George, T, Olivaires, J, Vsianska, M, Köhler, U, Lindeløv, B, Toftdahl, Db, Nielsen, Eb, Veyret, C, Castera, D, Kerbrat, P, Vassilaros, P, Yeo, W, Boni, C, Aitini, E, Luporini, G, Herben, Mg, Espelid, H, Dahl, S, Ingvar, C, Meana, A, Pico, C, Garcia, Am, Agrawal, Rk, Gruenberg, D, Nunez de Pierro, A, Gill, G, Nogaret, Jm, Honhon, B, Wassenaar, H, Nielander, R, Warnier, P, Sessa, C, Padrik, P, Guastalla, Jp, Serin, D, Jaubert, D, Dank, M, Given, Fh, Mascia, V, De Fraia, E, Silingardi, V, Conte, Pf, Labianca, R, Tondini, C, Bagnulo, A, Gardani, G, Wils, J, Liem, G, Nuytinck, Jk, Formoe, E, Ambré, T, Alés, J, Aramburo, P, Mansi, J, Graham, J, Joffe, J, Sainsbury, J, Stone, J, Good, Rh, Cartwright, T, Werner, Id, Murray, E, Beith, J, Tigges, Fj, Bojko, P, Sandberg, E, Jensen, B, Lotz, Jp, Carney, D, Shapira, J, Neumann, A, Goldhirsch, A, Dicato, M, de Graaf, H, Maartense, E, Burghouts, J, Cassinello, J, Jones, A, Gaffney, C, Blum, R, Abdi, E, Becquart, D, Dirix, L, Janssens, J, Nmarschner, N, Blaska Jaulerry, B, Prevot, G, Mirah Lev, L, Shani, A, Baruch, Nb, Peretz, T, Gips, M, Cognetti, F, Carlini, P, Nortier, Jw, Huinink D, ten B., Roussel, Jg, Unneberg, K, Kylberg, F, Hovind, H, Nestvold, T, Fogelkvist, R, Due, J, Muller, S, Gilligan, D, Russel, S, Mcaleer, J, Yiangou, C, Foote, L, Schottstaedt, M, Holmes, Fa, Wainstein, R, Contreras, O, Martinez, J, Della Fiorentina, S, Beslija, S, Vermorken, Jb, Thirion, M, Fraikin, J, Castiglione, M, Jäger, W, Fasching, P, Fabriz, H, Neis, K, Kirschbaum, M, Labat, Jp, Dupuis, O, Bernard, J, Datchary, J, Provencal, J, Allain, P, Clerico, M, Lopez, M, Nalli, G, Aspevik, R, Fràguas, A, Curescu, S, Cuevas, Jm, Oltra, A, Bradley, C, Kapoor, R, Akbain, S, Croghan, Mk, Modiano, M, Taetle, R, Beale, P, Gobert, P, Bondue, H, Böhm, R, Møller, Ka, Brettes, Jp, Netter, G, Grogan, L, Klein, B, Botta, M, Barni, S, Van Meerwijk, I, Kåresen, R, Godes, J, Aramburo, A, Jara, C, Zanger, B, Fleagle, Jt, Greenspan, A, Marschke, R, Medgyesy, Dc, Garbo, L.
Publikováno v:
The Lancet Oncology
lancet oncology, 13(4), 420-432. Lancet Publishing Group
lancet oncology, 13(4), 420-432. Lancet Publishing Group
BACKGROUND: Aromatase inhibitors are more effective than is tamoxifen in prevention of breast-cancer recurrence, but at the expense of increased musculoskeletal side-effects, such as carpal tunnel syndrome. The aim of this study was to assess risk fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f1b1d912af1429249258a5916fae06d
https://hdl.handle.net/1887/120204
https://hdl.handle.net/1887/120204
Autor:
Velikova G; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds Cancer Centre, St James's University Hospital, Leeds, UK. Electronic address: g.velikova@leeds.ac.uk., Morden JP; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds Cancer Centre, St James's University Hospital, Leeds, UK., Haviland JS; Institute of Cancer Research Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK., Emery C; Institute of Cancer Research Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK., Barrett-Lee P; Department of Oncology, Velindre University NHS Trust, Cardiff, UK., Earl H; Department of Oncology, University of Cambridge, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Bloomfield D; Department of Oncology, University Hospitals Sussex, Brighton, UK., Brunt AM; School of Medicine, University of Keele, Keele, UK; Department of Oncology, University Hospitals of North Midlands, Stoke-on-Trent, UK., Canney P; Beatson Oncology Center, Glasgow, UK., Coleman R; Department of Oncology, Weston Park Hospital, Sheffield, UK., Verrill M; Department of Oncology, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Wardley A; Outreach Research and Innovation Group, Manchester, UK., Bertelli G; Department of Oncology, University Hospitals Sussex, Brighton, UK., Ellis P; King's College London and Leaders in Oncology Care, London, UK., Stein R; University College London Hospitals, London, UK., Bliss JM; Institute of Cancer Research Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK., Cameron D; University of Edinburgh Cancer Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Dec; Vol. 24 (12), pp. 1359-1374. Date of Electronic Publication: 2023 Nov 02.
Autor:
Bliss JM; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK. Judith.bliss@icr.ac.uk., Tovey H; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Evans A; Poole Hospital, Poole, UK., Holcombe C; Royal Liverpool University Hospital, Liverpool, UK., Horgan K; Department of Breast Surgery, St James's University Hospital, Leeds, UK., Mallon E; Western Infirmary, Glasgow, UK., Vidya R; Royal Wolverhampton NHS Trust, Wolverhampton, UK., Skene A; Royal Bournemouth Hospital, Bournemouth, UK., Dodson A; UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, UK., Hills M; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, and Breast Cancer Now Centre, The Institute of Cancer Research, London, UK., Detre S; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, and Breast Cancer Now Centre, The Institute of Cancer Research, London, UK., Zabaglo L; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, and Breast Cancer Now Centre, The Institute of Cancer Research, London, UK., Banerji J; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Kilburn L; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Morden JP; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Robertson JFR; Royal Derby Hospital, University of Nottingham, Derby, UK., Smith I; Breast Unit, Royal Marsden Hospital, London, UK., Dowsett M; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, and Breast Cancer Now Centre, The Institute of Cancer Research, London, UK.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2023 Apr 12; Vol. 25 (1), pp. 39. Date of Electronic Publication: 2023 Apr 12.
Autor:
Bundred N; Manchester University NHS Foundation Trust and University of Manchester, Manchester, United Kingdom., Porta N; The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, United Kingdom., Brunt AM; University Hospitals of North Midlands and Keele University, United Kingdom., Cramer A; The Christie Pathology Partnership, Manchester, United Kingdom., Hanby A; Leeds Institute of Medical Research at St. James's, Leeds, United Kingdom., Shaaban AM; Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, United Kingdom., Rakha EA; University of Nottingham, Nottingham, United Kingdom., Armstrong A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Cutress RI; University of Southampton and University Hospital Southampton, Southampton, United Kingdom., Dodwell D; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Emson MA; The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, United Kingdom., Evans A; Poole Hospital NHS Foundation Trust, United Kingdom., Hartup SM; St James's University Hospital, Leeds, United Kingdom., Horgan K; St James's University Hospital, Leeds, United Kingdom., Miller SE; The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, United Kingdom., McIntosh SA; Queen's University Belfast, Belfast, United Kingdom., Morden JP; The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, United Kingdom., Naik J; Mid Yorkshire NHS Hospitals Trust, United Kingdom., Narayanan S; University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom., Ooi J; Royal Bolton Hospital, Manchester, United Kingdom., Skene AI; University of Southampton, Southampton, United Kingdom., Cameron DA; University of Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, United Kingdom., Bliss JM; The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 01; Vol. 28 (7), pp. 1323-1334.
Autor:
Nutting CM; The Royal Marsden Hospital, London, UK. Electronic address: chris.nutting@rmh.nhs.uk., Griffin CL; The Institute of Cancer Research, London, UK., Sanghera P; Queen Elizabeth Hospital, Birmingham, UK., Foran B; Weston Park Hospital, Sheffield, UK., Beasley M; Bristol Haematology & Oncology Centre, Bristol, UK., Bernstein D; Department of Physics, The Royal Marsden Hospital, London, UK., Cosgrove V; St James' Hospital, Leeds, UK., Fisher S; University of Leeds, Leeds, UK., West CM; University of Manchester, Manchester, UK., Sibtain A; St Bartholomew's Hospital, London, UK., Palaniappan N; Velindre Hospital, Cardiff, UK., Urbano TG; Guy's and St Thomas' Hospitals, London, UK., Sen M; St James' Hospital, Leeds, UK., Soe W; Glan Clywd, Rhyll, UK., Rizwanullah M; Beatson West of Scotland Cancer Centre, Glasgow, UK., Wood K; Royal Surrey County Hospital, Guildford, UK., Ramkumar S; Southampton General Hospital, Southampton, UK., Junor E; Western General Hospital, Edinburgh, UK., Cook A; Cheltenham General Hospital, Cheltenham, UK., Roques T; Norfolk and Norwich University Hospital, UK., Scrase C; Ipswich Hospital, Ipswich, UK., Bhide SA; The Royal Marsden Hospital, London, UK., Gujral D; The Royal Marsden Hospital, London, UK., Harrington KJ; The Royal Marsden Hospital, London, UK., Mehanna H; The Institute for Head and Neck Studies and Education, University of Birmingham, Birmingham, UK., Miah A; The Royal Marsden Hospital, London, UK., Emson M; The Institute of Cancer Research, London, UK., Gardiner D; The Institute of Cancer Research, London, UK., Morden JP; The Institute of Cancer Research, London, UK., Hall E; The Institute of Cancer Research, London, UK.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Aug; Vol. 153, pp. 242-256. Date of Electronic Publication: 2021 Jul 10.
Autor:
Judson I; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Ian.Judson@icr.ac.uk., Morden JP; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Kilburn L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Leahy M; The Christie NHS Foundation Trust, Manchester, UK., Benson C; The Royal Marsden NHS Foundation Trust, London, UK., Bhadri V; Chris O'Brien Lifehouse, Sydney, NSW, Australia., Campbell-Hewson Q; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Cubedo R; Hospital Puerta de Hierro, Madrid, Spain., Dangoor A; University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Fox L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Hennig I; Nottingham University Hospitals NHS Trust, Nottingham, UK., Jarman K; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Joubert W; Princess Alexandra Hospital, Brisbane, QLD, Australia., Kernaghan S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., López Pousa A; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., McNeil C; Chris O'Brien Lifehouse, Sydney, NSW, Australia., Seddon B; University College London Hospitals NHS Foundation Trust, London, UK., Snowdon C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Tattersall M; Chris O'Brien Lifehouse, Sydney, NSW, Australia., Toms C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Martinez Trufero J; Hospital Miguel Servet, Zaragoza, Spain., Bliss JM; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Jul; Vol. 20 (7), pp. 1023-1034. Date of Electronic Publication: 2019 May 31.
Autor:
Nutting CM; Head and Neck Unit, Royal Marsden Hospital, London, United Kingdom. Electronic address: Chris.Nutting@rmh.nhs.uk., Morden JP; The Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Beasley M; Bristol Cancer Institute, Bristol Haematology and Oncology Centre, United Kingdom., Bhide S; Head and Neck Unit, Royal Marsden Hospital, London, United Kingdom., Cook A; Gloucestershire Oncology Centre, Cheltenham General Hospital, United Kingdom., De Winton E; Department of Oncology, Royal United Hospital, Bath, United Kingdom., Emson M; The Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Evans M; Clinical Oncology, Velindre NHS Trust, United Kingdom., Fresco L; Department of Oncology, University Hospitals of Coventry and Warwickshire, United Kingdom., Gollins S; Department of Oncology, Glan Clwyd Hospital, Rhyl, United Kingdom., Gujral D; Head and Neck Department, Imperial College Healthcare NHS Trust, United Kingdom; Sarcoma Unit, Royal Marsden Hospital, Sutton, United Kingdom., Harrington K; Head and Neck Unit, Royal Marsden Hospital, London, United Kingdom., Joseph M; Oncology and Haematology Directorate, The Royal Wolverhampton NHS Trust, United Kingdom., Lemon C; Department of Oncology, Mount Vernon Hospital, United Kingdom., Luxon L; University College London Ear Institute, United Kingdom., van den Blink Q; Department of Oncology, Northampton General Hospital, United Kingdom., Mendes R; Department of Oncology, University College Hospital, London, United Kingdom., Miah A; Head and Neck Department, Imperial College Healthcare NHS Trust, United Kingdom; Sarcoma Unit, Royal Marsden Hospital, Sutton, United Kingdom., Newbold K; Head and Neck Unit, Royal Marsden Hospital, London, United Kingdom., Prestwich R; Department of Clinical Oncology, St James's University Hospital, Leeds, United Kingdom., Robinson M; Department of Clinical Oncology, Weston Park Hospital, Sheffield, United Kingdom., Sanghera P; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, United Kingdom., Simpson J; Department of Oncology, Royal Sussex County Hospital, United Kingdom., Sivaramalingam M; Department of Oncology, Royal Preston Hospital, United Kingdom., Srihari NN; Department of Oncology, Royal Shrewsbury Hospital, United Kingdom., Sydenham M; The Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Wells E; QA Physics, Royal Marsden Hospital, London, United Kingdom., Witts S; The Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Hall E; The Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2018 Nov; Vol. 103, pp. 249-258. Date of Electronic Publication: 2018 Oct 01.
Autor:
Blok EJ; Department of Surgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Engels CC; Department of Surgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Dekker-Ensink G; Department of Surgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Meershoek-Klein Kranenbarg E; Department of Surgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Liefers GJ; Department of Surgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Morden JP; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, UK., Bliss JM; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, UK., Coombes RC; Department of Surgery & Cancer, Imperial College, London, UK., Bartlett JMS; Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van de Velde CJH; Department of Surgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Kuppen PJK; Department of Surgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. p.j.k.kuppen@lumc.nl.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Aug; Vol. 171 (1), pp. 65-74. Date of Electronic Publication: 2018 May 15.